Clinical Agenda

Day 1
Nov 09 2017
Day 2
Nov 10 2017
Day 3
Nov 11 2017

CLINICAL TRACK
Session I-A: The Multidisciplinary, Patient Centered Approach to IBD Care

11:55 am

Welcome and introduction

12:00 pm

Rationale for a multidisciplinary, patient-centered approach to IBD care

12:20 pm

Management of psycho-social issues for IBD patients and their families

12:40 pm

The multidisciplinary surgical approach to IBD patient care

1:00 pm

The pediatric-adult transition: How to bridge the change

1:20 pm

Novel approaches to improve caregiver-patient interactions using integrated models

1:40 pm

Panel discussion

2:00 pm

Break

CLINICAL TRACK
Session II-A: The Changing Healthcare Landscape

2:30 pm

Will changes in healthcare legislation impact IBD patient care?

2:50 pm

How can the caregiver better navigate medication choice and cost hurdles?

3:10 pm

What should medical centers and administrators do in order to optimize patient care in our complex environment

3:30 pm

Advances in information technology that will improve patient care: Electronic medical records, the internet, social media, telemedicine, and remote video-medicine

3:50 pm

What we can learn from the European Crohn's and Colitis Organization's approaches to IBD Education and IBD Guidelines

4:10 pm

Panel discussion

4:40 pm

Break

CLINICAL TRACK
Session III-A: New and Emerging Therapeutic Approaches for IBD

5:10 pm

The treatment of moderate to severe IBD with anti-TNF Biologics and Immunomodulators

5:30 pm

Optimizing adhesion molecule-based therapies

5:50 pm

Understanding the use of IL12/IL23 targeted Biologics

6:10 pm

Future IBD therapies

6:30 pm

Panel discussion

7:00 pm

Adjourn and Reception

CLINICAL TRACK
Session IV-A: Making the Choice of Therapy for Crohn’s Disease: How Evidence Impacts Practice

7:55 am

Welcome and introduction

8:00 am

Debates:

How to use Cochrane reviews and guidelines for evidence based decision making

How to decide which therapy to use: When and where the evidence ends

8:20 am

Debate discussion

8:30 am

Presentation #1: Use of anti-TNF therapies for Crohn's disease

8:40 am

Presentation #1: Cases with debate and discussion

9:00 am

Presentation #2: Use of adhesion molecule-based therapies for Crohn's disease

9:10 am

Presentation #2: Cases with debate and discussion

9:30 am

Presentation #3: Use of IL12/IL23 targeted therapies for Crohn's disease

9:40 am

Presentation #3: Cases with debate and discussion

10:00 am

Break

CLINICAL TRACK
Session V-A: Case Discussions in IBD

10:30 am

Case Discussion I: Management of infections in IBD patients on immunomodulators and/or biologics

11:00 am

Case Discussion II: Challenges in the care of the pregnant IBD patient

11:30 am

Case Discussion III: When and how to modify IBD therapies: Increasing, maintaining or de-escalating biologics and/or immunomodulators; Future use of combination biologics

12:00 pm

Case Discussion IV: Controversies in the surgical management of complicated Crohn's disease

12:30 pm

Lunch and satellite symposia

CLINICAL TRACK
Session VI-A: Case-based Clinical Breakout Session

2:00 pm

A: The outpatient with severe, refractory Crohn's disease, who failed prior biologics: Case studies

B. Extra-intestinal manifestations of IBD: Case studies

C. Challenges in the surgical management of severe, refractory ulcerative colitis: Case studies with videos

D. Sexual Dysfunction in IBD: Case studies

E. Treating IBD patients with stress, anxiety, and/or depression: Case studies

F. When should the asymptomatic or mildly symptomatic IBD patient be treated? Case studies

2:45 pm

Case-based sessions end: Participants have 15 minutes to move to new session

3:00 pm

A: The outpatient with severe, refractory Crohn's disease, who failed prior biologics: Case studies

B. Extra-intestinal manifestations of IBD: Case studies

C. Challenges in the surgical management of severe, refractory ulcerative colitis: Case studies with videos

D. Sexual Dysfunction in IBD: Case studies

E. Treating IBD patients with stress, anxiety, and/or depression: Case studies

F. When should the asymptomatic or mildly symptomatic IBD patient be treated? Case studies

3:45 pm

Break

CLINICAL TRACK
Session VII-A: Deciphering an IBD Operative Report: What Every Gastroenterologist Should Know

4:20 pm

Small bowel resection/stricturoplasty

4:40 pm

Ileocolic resection

5:00 pm

Ileal pouch-anal anastomosis

5:20 pm

Failing ileal J pouch

5:40 pm

Perianal abscess and fistula

6:00 pm

Panel discussion

CLINICAL TRACK
Session VIII-A: Advances in Endoscopy for IBD

7:55 am

Welcome and introduction

8:00 am

Use of endoscopy to evaluate esophageal, gastric, and duodenal Crohn’s disease (videos)

8:20 am

How to access and determine the severity and complications of small bowel Crohn’s disease (videos)

8:40 am

What is the role of initial and repeat colonoscopies in the setting of severe colitis (videos)

9:00 am

Diagnosis and management of dysplasia and polyps in chronic ulcerative colitis (videos)

9:20 am

Modalities used to evaluate the differential diagnosis of refractory pouchitis (videos)

9:40 am

Panel discussion

10:00 am

Break

CLINICAL TRACK
Session IX-A: Patient-related Factors Affecting IBD Management

10:30 am

Caring for the patient with multiple co-morbidities

10:50 am

The use of complementary and alternative medications

11:10 am

Overlooked issues that will optimize the health of our patients

11:30 am

Prevention and management of side effects of therapies during pregnancy and postpartum

11:50 am

How to treat chronic pain and avoid narcotic dependence

12:10 pm

Panel discussion

12:30 pm

Lunch break and satellite symposia

CLINICAL TRACK
Session X-A: Case-based Clinical Breakout Sessions

2:00 pm

A. Challenging IBD patients with concurrent liver disease: Case studies

B. Treatment of complicated ulcerative colitis patients following surgery: Case studies with videos

C. Managing IBD patients with a prior or current malignancy: Case Studies

D. Recognizing and managing side effects due to medications used to treat IBD: Case studies

E. Reassessing immunomodulators: Which patient, which drug, and which dose: Case studies

F. Use of therapeutic endoscopic techniques to manage complications of Crohn's disease

2:45 pm

Case-based sessions end: Participants have 15 minutes to move to new session

3:00 pm

A. Challenging IBD patients with concurrent liver disease: Case studies

B. Treatment of complicated ulcerative colitis patients following surgery: Case studies with videos

C. Managing IBD patients with a prior or current malignancy: Case Studies

D. Recognizing and managing side effects due to medications used to treat IBD: Case studies

E. Reassessing immunomodulators: Which patient, which drug, and which dose: Case studies

F. Use of therapeutic endoscopic techniques to manage complications of Crohn's disease

3:45 pm

Break

CLINICAL TRACK
Session XI-A: Progress in IBD Patient Care

4:00 pm

Defining an IBD patient's disease severity and prognosis

4:20 pm

Therapeutic drug monitoring: When, why, and how

4:40 pm

Challenges in treating the elderly patient with IBD

5:00 pm

Clostridia difficile in IBD

5:20 pm

Panel discussion

5:40 pm

Adjourn